ENTASIS THERAPEUTICS LIMITED
LONDON

Hellopages » Greater London » Westminster » W2 6BD

Company number 09475809
Status Active
Incorporation Date 6 March 2015
Company Type Private Limited Company
Address 2 KINGDOM STREET, LONDON, ENGLAND, W2 6BD
Home Country United Kingdom
Nature of Business 82990 - Other business support service activities n.e.c.
Phone, email, etc

Since the company registration twenty-six events have happened. The last three records are Full accounts made up to 31 December 2015; Resolutions RES01 ‐ Resolution of adoption of Articles of Association ; Appointment of Mr Michael John Gutch as a director on 29 March 2016. The most likely internet sites of ENTASIS THERAPEUTICS LIMITED are www.entasistherapeutics.co.uk, and www.entasis-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and eleven months. The distance to to Battersea Park Rail Station is 3.3 miles; to Barbican Rail Station is 3.7 miles; to Barnes Bridge Rail Station is 4.4 miles; to Brentford Rail Station is 5.9 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Entasis Therapeutics Limited is a Private Limited Company. The company registration number is 09475809. Entasis Therapeutics Limited has been working since 06 March 2015. The present status of the company is Active. The registered address of Entasis Therapeutics Limited is 2 Kingdom Street London England W2 6bd. . CONACHER, Matthew Ian is a Secretary of the company. BISGAARD, Peter Tuxen is a Director of the company. GALAKATOS, Nicholas is a Director of the company. GUTCH, Michael John is a Director of the company. PERROS, Manoussos, Dr is a Director of the company. STAPLES, Andrew James is a Director of the company. TOPPER, James is a Director of the company. Director CONACHER, Matthew Ian has been resigned. Director GREPINET, Rodolphe Peter Andre has been resigned. Director KEMP, Adrian Charles Noel has been resigned. Director O'GRADY, Claire-Marie has been resigned. Director SNOWDEN, Michael Alexander, Dr has been resigned. The company operates in "Other business support service activities n.e.c.".


Current Directors

Secretary
CONACHER, Matthew Ian
Appointed Date: 11 May 2015

Director
BISGAARD, Peter Tuxen
Appointed Date: 29 March 2016
52 years old

Director
GALAKATOS, Nicholas
Appointed Date: 29 March 2016
68 years old

Director
GUTCH, Michael John
Appointed Date: 29 March 2016
59 years old

Director
PERROS, Manoussos, Dr
Appointed Date: 11 May 2015
58 years old

Director
STAPLES, Andrew James
Appointed Date: 11 May 2015
56 years old

Director
TOPPER, James
Appointed Date: 29 March 2016
63 years old

Resigned Directors

Director
CONACHER, Matthew Ian
Resigned: 11 May 2015
Appointed Date: 21 April 2015
42 years old

Director
GREPINET, Rodolphe Peter Andre
Resigned: 29 March 2016
Appointed Date: 11 May 2015
52 years old

Director
KEMP, Adrian Charles Noel
Resigned: 11 May 2015
Appointed Date: 06 March 2015
59 years old

Director
O'GRADY, Claire-Marie
Resigned: 07 May 2015
Appointed Date: 06 March 2015
57 years old

Director
SNOWDEN, Michael Alexander, Dr
Resigned: 29 March 2016
Appointed Date: 11 May 2015
62 years old

ENTASIS THERAPEUTICS LIMITED Events

07 Oct 2016
Full accounts made up to 31 December 2015
14 Apr 2016
Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association

12 Apr 2016
Appointment of Mr Michael John Gutch as a director on 29 March 2016
08 Apr 2016
Appointment of Mr James Topper as a director on 29 March 2016
08 Apr 2016
Appointment of Mr Peter Tuxen Bisgaard as a director on 29 March 2016
...
... and 16 more events
22 May 2015
Statement of capital following an allotment of shares on 11 May 2015
  • USD 33,500,000

22 May 2015
Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES01 ‐ Resolution of adoption of Articles of Association

24 Apr 2015
Appointment of Mr Matthew Ian Conacher as a director on 21 April 2015
14 Apr 2015
Current accounting period shortened from 31 March 2016 to 31 December 2015
06 Mar 2015
Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

Statement of capital on 2015-03-06
  • USD 100